nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenazopyridine—SCN3A—spinal nerve—peripheral nervous system neoplasm	0.0991	0.269	CbGeAlD
Phenazopyridine—SCN11A—nerve—peripheral nervous system neoplasm	0.0413	0.112	CbGeAlD
Phenazopyridine—SCN11A—ganglion—peripheral nervous system neoplasm	0.0408	0.111	CbGeAlD
Phenazopyridine—SCN8A—nerve—peripheral nervous system neoplasm	0.0313	0.0851	CbGeAlD
Phenazopyridine—SCN5A—Cardiac Progenitor Differentiation—LIN28B—peripheral nervous system neoplasm	0.0219	0.0551	CbGpPWpGaD
Phenazopyridine—SCN10A—nerve—peripheral nervous system neoplasm	0.0209	0.0569	CbGeAlD
Phenazopyridine—SCN10A—ganglion—peripheral nervous system neoplasm	0.0207	0.0562	CbGeAlD
Phenazopyridine—SCN11A—trigeminal ganglion—peripheral nervous system neoplasm	0.02	0.0545	CbGeAlD
Phenazopyridine—SCN7A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.0174	0.0438	CbGpPWpGaD
Phenazopyridine—SCN7A—trigeminal ganglion—peripheral nervous system neoplasm	0.017	0.0463	CbGeAlD
Phenazopyridine—SCN11A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.0155	0.039	CbGpPWpGaD
Phenazopyridine—SCN8A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.0142	0.0357	CbGpPWpGaD
Phenazopyridine—SCN8A—brainstem—peripheral nervous system neoplasm	0.0134	0.0365	CbGeAlD
Phenazopyridine—SCN9A—trigeminal ganglion—peripheral nervous system neoplasm	0.0133	0.0363	CbGeAlD
Phenazopyridine—Digestion impaired—Melphalan—peripheral nervous system neoplasm	0.0121	0.0515	CcSEcCtD
Phenazopyridine—SCN9A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.0115	0.0289	CbGpPWpGaD
Phenazopyridine—SCN3A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.011	0.0276	CbGpPWpGaD
Phenazopyridine—SCN4A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.0105	0.0265	CbGpPWpGaD
Phenazopyridine—SCN2A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.0105	0.0265	CbGpPWpGaD
Phenazopyridine—SCN1A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.0102	0.0256	CbGpPWpGaD
Phenazopyridine—SCN10A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.0102	0.0256	CbGpPWpGaD
Phenazopyridine—SCN10A—trigeminal ganglion—peripheral nervous system neoplasm	0.0102	0.0276	CbGeAlD
Phenazopyridine—SCN1A—brainstem—peripheral nervous system neoplasm	0.0102	0.0276	CbGeAlD
Phenazopyridine—SCN2A—brainstem—peripheral nervous system neoplasm	0.00932	0.0253	CbGeAlD
Phenazopyridine—SCN7A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.0085	0.0214	CbGpPWpGaD
Phenazopyridine—SCN11A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00758	0.0191	CbGpPWpGaD
Phenazopyridine—SCN5A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00715	0.018	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00699	0.0176	CbGpPWpGaD
Phenazopyridine—SCN8A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00693	0.0174	CbGpPWpGaD
Phenazopyridine—SCN8A—cerebellum—peripheral nervous system neoplasm	0.00662	0.018	CbGeAlD
Phenazopyridine—SCN7A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00658	0.0165	CbGpPWpGaD
Phenazopyridine—Haemolytic anaemia—Melphalan—peripheral nervous system neoplasm	0.0065	0.0277	CcSEcCtD
Phenazopyridine—Visual disturbance—Isotretinoin—peripheral nervous system neoplasm	0.00628	0.0267	CcSEcCtD
Phenazopyridine—Visual disturbance—Tretinoin—peripheral nervous system neoplasm	0.00628	0.0267	CcSEcCtD
Phenazopyridine—SCN11A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00586	0.0147	CbGpPWpGaD
Phenazopyridine—SCN5A—Cardiac Progenitor Differentiation—NCAM1—peripheral nervous system neoplasm	0.00561	0.0141	CbGpPWpGaD
Phenazopyridine—SCN9A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.0056	0.0141	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00536	0.0135	CbGpPWpGaD
Phenazopyridine—SCN3A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00536	0.0135	CbGpPWpGaD
Phenazopyridine—SCN4A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00515	0.013	CbGpPWpGaD
Phenazopyridine—SCN2A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00515	0.013	CbGpPWpGaD
Phenazopyridine—SCN1A—cerebellum—peripheral nervous system neoplasm	0.00501	0.0136	CbGeAlD
Phenazopyridine—SCN1A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00497	0.0125	CbGpPWpGaD
Phenazopyridine—SCN10A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00497	0.0125	CbGpPWpGaD
Phenazopyridine—Visual disturbance—Alitretinoin—peripheral nervous system neoplasm	0.00476	0.0203	CcSEcCtD
Phenazopyridine—SCN7A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00469	0.0118	CbGpPWpGaD
Phenazopyridine—SCN2A—cerebellum—peripheral nervous system neoplasm	0.00459	0.0125	CbGeAlD
Phenazopyridine—Jaundice—Melphalan—peripheral nervous system neoplasm	0.00441	0.0188	CcSEcCtD
Phenazopyridine—SCN9A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00434	0.0109	CbGpPWpGaD
Phenazopyridine—Haemolytic anaemia—Cisplatin—peripheral nervous system neoplasm	0.00425	0.0181	CcSEcCtD
Phenazopyridine—SCN11A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00418	0.0105	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00415	0.0104	CbGpPWpGaD
Phenazopyridine—Hepatitis—Tretinoin—peripheral nervous system neoplasm	0.00412	0.0175	CcSEcCtD
Phenazopyridine—Hepatitis—Isotretinoin—peripheral nervous system neoplasm	0.00412	0.0175	CcSEcCtD
Phenazopyridine—Hepatitis—Melphalan—peripheral nervous system neoplasm	0.00406	0.0173	CcSEcCtD
Phenazopyridine—SCN3A—cerebellum—peripheral nervous system neoplasm	0.00404	0.011	CbGeAlD
Phenazopyridine—SCN2A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00398	0.01	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00398	0.01	CbGpPWpGaD
Phenazopyridine—Visual impairment—Isotretinoin—peripheral nervous system neoplasm	0.00397	0.0169	CcSEcCtD
Phenazopyridine—Visual impairment—Tretinoin—peripheral nervous system neoplasm	0.00397	0.0169	CcSEcCtD
Phenazopyridine—SCN10A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00384	0.00967	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00384	0.00967	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00383	0.00962	CbGpPWpGaD
Phenazopyridine—SCN5A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00349	0.00878	CbGpPWpGaD
Phenazopyridine—Hepatitis—Dactinomycin—peripheral nervous system neoplasm	0.00336	0.0143	CcSEcCtD
Phenazopyridine—SCN7A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00321	0.00808	CbGpPWpGaD
Phenazopyridine—Hepatitis—Alitretinoin—peripheral nervous system neoplasm	0.00312	0.0133	CcSEcCtD
Phenazopyridine—SCN9A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00309	0.00778	CbGpPWpGaD
Phenazopyridine—Visual impairment—Alitretinoin—peripheral nervous system neoplasm	0.00301	0.0128	CcSEcCtD
Phenazopyridine—SCN3A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00296	0.00745	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00286	0.0072	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00284	0.00715	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00284	0.00715	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00274	0.0069	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00274	0.0069	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.0027	0.0068	CbGpPWpGaD
Phenazopyridine—Jaundice—Etoposide—peripheral nervous system neoplasm	0.00264	0.0113	CcSEcCtD
Phenazopyridine—SCN8A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00262	0.00659	CbGpPWpGaD
Phenazopyridine—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.00259	0.011	CcSEcCtD
Phenazopyridine—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.00257	0.011	CcSEcCtD
Phenazopyridine—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.00257	0.011	CcSEcCtD
Phenazopyridine—Visual impairment—Cisplatin—peripheral nervous system neoplasm	0.00256	0.0109	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.00254	0.0108	CcSEcCtD
Phenazopyridine—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.00254	0.0108	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.00252	0.0107	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.00252	0.0107	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.00249	0.0106	CcSEcCtD
Phenazopyridine—SCN7A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.00229	0.00577	CbGpPWpGaD
Phenazopyridine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00217	0.00925	CcSEcCtD
Phenazopyridine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00215	0.00917	CcSEcCtD
Phenazopyridine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00215	0.00917	CcSEcCtD
Phenazopyridine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00213	0.00905	CcSEcCtD
Phenazopyridine—SCN9A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00212	0.00533	CbGpPWpGaD
Phenazopyridine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00209	0.00888	CcSEcCtD
Phenazopyridine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00207	0.00881	CcSEcCtD
Phenazopyridine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00207	0.00881	CcSEcCtD
Phenazopyridine—SCN11A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.00204	0.00514	CbGpPWpGaD
Phenazopyridine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00204	0.00869	CcSEcCtD
Phenazopyridine—SCN3A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00203	0.0051	CbGpPWpGaD
Phenazopyridine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00202	0.00859	CcSEcCtD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.00201	0.00506	CbGpPWpGaD
Phenazopyridine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.002	0.00852	CcSEcCtD
Phenazopyridine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.002	0.00852	CcSEcCtD
Phenazopyridine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00197	0.00841	CcSEcCtD
Phenazopyridine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00195	0.00831	CcSEcCtD
Phenazopyridine—SCN2A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00195	0.0049	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00195	0.0049	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00193	0.00485	CbGpPWpGaD
Phenazopyridine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00191	0.00815	CcSEcCtD
Phenazopyridine—SCN10A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00188	0.00472	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00188	0.00472	CbGpPWpGaD
Phenazopyridine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00187	0.00798	CcSEcCtD
Phenazopyridine—SCN8A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.00187	0.0047	CbGpPWpGaD
Phenazopyridine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00186	0.00792	CcSEcCtD
Phenazopyridine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00186	0.00792	CcSEcCtD
Phenazopyridine—Rash—Topotecan—peripheral nervous system neoplasm	0.00186	0.00791	CcSEcCtD
Phenazopyridine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00186	0.00791	CcSEcCtD
Phenazopyridine—Headache—Topotecan—peripheral nervous system neoplasm	0.00185	0.00786	CcSEcCtD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.00184	0.00464	CbGpPWpGaD
Phenazopyridine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00184	0.00785	CcSEcCtD
Phenazopyridine—Rash—Tretinoin—peripheral nervous system neoplasm	0.00184	0.00785	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00184	0.00785	CcSEcCtD
Phenazopyridine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00184	0.00784	CcSEcCtD
Phenazopyridine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00184	0.00784	CcSEcCtD
Phenazopyridine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00183	0.00781	CcSEcCtD
Phenazopyridine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00183	0.0078	CcSEcCtD
Phenazopyridine—Headache—Tretinoin—peripheral nervous system neoplasm	0.00183	0.0078	CcSEcCtD
Phenazopyridine—Rash—Melphalan—peripheral nervous system neoplasm	0.00182	0.00775	CcSEcCtD
Phenazopyridine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00182	0.00774	CcSEcCtD
Phenazopyridine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00176	0.0075	CcSEcCtD
Phenazopyridine—Nausea—Topotecan—peripheral nervous system neoplasm	0.00175	0.00745	CcSEcCtD
Phenazopyridine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00174	0.0074	CcSEcCtD
Phenazopyridine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00174	0.0074	CcSEcCtD
Phenazopyridine—Nausea—Melphalan—peripheral nervous system neoplasm	0.00171	0.0073	CcSEcCtD
Phenazopyridine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00164	0.00696	CcSEcCtD
Phenazopyridine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00163	0.00695	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00163	0.00694	CcSEcCtD
Phenazopyridine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00157	0.0067	CcSEcCtD
Phenazopyridine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00157	0.00668	CcSEcCtD
Phenazopyridine—SCN7A—Axon guidance—MET—peripheral nervous system neoplasm	0.00153	0.00386	CbGpPWpGaD
Phenazopyridine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00152	0.00647	CcSEcCtD
Phenazopyridine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00152	0.00646	CcSEcCtD
Phenazopyridine—SCN9A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.00151	0.0038	CbGpPWpGaD
Phenazopyridine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00151	0.00642	CcSEcCtD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.0015	0.00378	CbGpPWpGaD
Phenazopyridine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00149	0.00636	CcSEcCtD
Phenazopyridine—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.00148	0.00631	CcSEcCtD
Phenazopyridine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00146	0.00622	CcSEcCtD
Phenazopyridine—SCN3A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.00145	0.00364	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.00142	0.00357	CbGpPWpGaD
Phenazopyridine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00142	0.00604	CcSEcCtD
Phenazopyridine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00141	0.006	CcSEcCtD
Phenazopyridine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.0014	0.00595	CcSEcCtD
Phenazopyridine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.0014	0.00594	CcSEcCtD
Phenazopyridine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00139	0.00592	CcSEcCtD
Phenazopyridine—SCN2A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.00139	0.00349	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.00139	0.00349	CbGpPWpGaD
Phenazopyridine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00139	0.00591	CcSEcCtD
Phenazopyridine—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.00137	0.00584	CcSEcCtD
Phenazopyridine—SCN11A—Axon guidance—MET—peripheral nervous system neoplasm	0.00137	0.00344	CbGpPWpGaD
Phenazopyridine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.00136	0.00581	CcSEcCtD
Phenazopyridine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00136	0.00578	CcSEcCtD
Phenazopyridine—Rash—Vincristine—peripheral nervous system neoplasm	0.00135	0.00573	CcSEcCtD
Phenazopyridine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00134	0.00573	CcSEcCtD
Phenazopyridine—SCN1A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.00134	0.00337	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.00134	0.00337	CbGpPWpGaD
Phenazopyridine—Headache—Vincristine—peripheral nervous system neoplasm	0.00134	0.0057	CcSEcCtD
Phenazopyridine—SCN5A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00132	0.00332	CbGpPWpGaD
Phenazopyridine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00132	0.0056	CcSEcCtD
Phenazopyridine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.00132	0.0056	CcSEcCtD
Phenazopyridine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00129	0.0055	CcSEcCtD
Phenazopyridine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00127	0.00543	CcSEcCtD
Phenazopyridine—Nausea—Vincristine—peripheral nervous system neoplasm	0.00127	0.0054	CcSEcCtD
Phenazopyridine—SCN11A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.00127	0.00318	CbGpPWpGaD
Phenazopyridine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.00126	0.00538	CcSEcCtD
Phenazopyridine—SCN8A—Axon guidance—MET—peripheral nervous system neoplasm	0.00125	0.00315	CbGpPWpGaD
Phenazopyridine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00122	0.00521	CcSEcCtD
Phenazopyridine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.00122	0.00518	CcSEcCtD
Phenazopyridine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.0012	0.00511	CcSEcCtD
Phenazopyridine—Rash—Cisplatin—peripheral nervous system neoplasm	0.00119	0.00507	CcSEcCtD
Phenazopyridine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00119	0.00506	CcSEcCtD
Phenazopyridine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00118	0.00504	CcSEcCtD
Phenazopyridine—SCN8A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.00116	0.00291	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.00112	0.00282	CbGpPWpGaD
Phenazopyridine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00112	0.00478	CcSEcCtD
Phenazopyridine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.0011	0.00468	CcSEcCtD
Phenazopyridine—SCN7A—Developmental Biology—MET—peripheral nervous system neoplasm	0.0011	0.00276	CbGpPWpGaD
Phenazopyridine—Rash—Etoposide—peripheral nervous system neoplasm	0.00109	0.00464	CcSEcCtD
Phenazopyridine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00109	0.00464	CcSEcCtD
Phenazopyridine—Headache—Etoposide—peripheral nervous system neoplasm	0.00108	0.00461	CcSEcCtD
Phenazopyridine—Nausea—Etoposide—peripheral nervous system neoplasm	0.00103	0.00437	CcSEcCtD
Phenazopyridine—SCN7A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.00101	0.00255	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—MET—peripheral nervous system neoplasm	0.00101	0.00255	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.001	0.00252	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000976	0.00246	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—MET—peripheral nervous system neoplasm	0.000968	0.00244	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000941	0.00237	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000936	0.00235	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—MET—peripheral nervous system neoplasm	0.00093	0.00234	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—MET—peripheral nervous system neoplasm	0.00093	0.00234	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000915	0.0023	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000903	0.00227	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—MET—peripheral nervous system neoplasm	0.000897	0.00226	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—MET—peripheral nervous system neoplasm	0.000897	0.00226	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000895	0.00225	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000893	0.00225	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.00086	0.00216	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.00086	0.00216	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000854	0.00215	CbGpPWpGaD
Phenazopyridine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000853	0.00363	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000837	0.00356	CcSEcCtD
Phenazopyridine—SCN10A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000829	0.00209	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000829	0.00209	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000826	0.00208	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000801	0.00201	CbGpPWpGaD
Phenazopyridine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.00079	0.00336	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000774	0.0033	CcSEcCtD
Phenazopyridine—SCN11A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000761	0.00191	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000751	0.00189	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.00074	0.00186	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000722	0.00182	CbGpPWpGaD
Phenazopyridine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000714	0.00304	CcSEcCtD
Phenazopyridine—SCN11A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000714	0.0018	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000707	0.00178	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000696	0.00175	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000691	0.00174	CbGpPWpGaD
Phenazopyridine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000686	0.00292	CcSEcCtD
Phenazopyridine—SCN4A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.00068	0.00171	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.00068	0.00171	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000668	0.00168	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000664	0.00167	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000664	0.00167	CbGpPWpGaD
Phenazopyridine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000663	0.00282	CcSEcCtD
Phenazopyridine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000661	0.00281	CcSEcCtD
Phenazopyridine—SCN10A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000655	0.00165	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000655	0.00165	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000653	0.00164	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—MET—peripheral nervous system neoplasm	0.00064	0.00161	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—MET—peripheral nervous system neoplasm	0.00064	0.00161	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000639	0.00161	CbGpPWpGaD
Phenazopyridine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000635	0.0027	CcSEcCtD
Phenazopyridine—SCN5A—Axon guidance—MET—peripheral nervous system neoplasm	0.00063	0.00159	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000624	0.00157	CbGpPWpGaD
Phenazopyridine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000616	0.00262	CcSEcCtD
Phenazopyridine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000614	0.00261	CcSEcCtD
Phenazopyridine—SCN2A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000614	0.00154	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000614	0.00154	CbGpPWpGaD
Phenazopyridine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000611	0.0026	CcSEcCtD
Phenazopyridine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000611	0.0026	CcSEcCtD
Phenazopyridine—SCN7A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000609	0.00153	CbGpPWpGaD
Phenazopyridine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000607	0.00259	CcSEcCtD
Phenazopyridine—SCN10A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000592	0.00149	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000592	0.00149	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000583	0.00147	CbGpPWpGaD
Phenazopyridine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000576	0.00245	CcSEcCtD
Phenazopyridine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.00057	0.00243	CcSEcCtD
Phenazopyridine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000566	0.00241	CcSEcCtD
Phenazopyridine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000565	0.00241	CcSEcCtD
Phenazopyridine—SCN9A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000563	0.00142	CbGpPWpGaD
Phenazopyridine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000562	0.00239	CcSEcCtD
Phenazopyridine—SCN11A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000557	0.0014	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000543	0.00137	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000538	0.00135	CbGpPWpGaD
Phenazopyridine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000533	0.00227	CcSEcCtD
Phenazopyridine—SCN9A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000528	0.00133	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000517	0.0013	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000517	0.0013	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000509	0.00128	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000505	0.00127	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000499	0.00125	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000499	0.00125	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000497	0.00125	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000485	0.00122	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000485	0.00122	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000468	0.00118	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000468	0.00118	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000461	0.00116	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—MET—peripheral nervous system neoplasm	0.00045	0.00113	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000446	0.00112	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000416	0.00105	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000412	0.00104	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000402	0.00101	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000397	0.000999	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000394	0.000991	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000393	0.00099	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000384	0.000966	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000378	0.000952	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000378	0.000952	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000369	0.000928	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000369	0.000928	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000365	0.000918	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000365	0.000918	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000363	0.000914	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000356	0.000895	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000356	0.000895	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000351	0.000882	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000351	0.000882	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000329	0.000827	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000321	0.000807	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000294	0.000739	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000281	0.000707	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.00027	0.000679	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.00027	0.000679	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.00026	0.000655	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.00026	0.000655	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000259	0.000653	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000256	0.000645	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.00025	0.000629	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000248	0.000624	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000238	0.0006	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000238	0.0006	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.00023	0.000578	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.00023	0.000578	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000183	0.00046	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000162	0.000407	CbGpPWpGaD
